Genes from a translational analysis support a multifactorial nature of white matter hyperintensities

Stroke

Volumn 46, Issue 2, 2015, Pages 341-347

  Lopez, Lorna M ^a   Hill, W David ^a   Harris, Sarah E ^a   Valdes Hernandez, Maria ^a   Munoz Maniega, Susana ^a   Bastin, Mark E ^a   Bailey, Emma ^c   Smith, Colin ^b   McBride, Martin ^d   McClure, John ^d   Graham, Delyth ^d   Dominiczak, Anna ^d   Yang, Qiong ^e,f   Fornage, Myriam ^g   Ikram, M Arfan ^h,i   Debette, Stephanie ^j,k,l,m   Launer, Lenore ⁿ   Bis, Joshua C ^o   Schmidt, Reinhold ^p   Seshadri, Sudha ^f,m   Porteous, David J ^a   Starr, John ^a   Deary, Ian J ^a   Wardlaw, Joanna M ^a   more..

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f FRAMINGHAM HEART STUDY   (United States)

^g UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ Netherlands Consortium for Healthy Ageing   (Netherlands)

^j INSERM   (France)

^k HÔPITAL LARIBOISIÈRE   (France)

^l LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^m BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ NATIONAL INSTITUTE ON AGING   (United States)

^o UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^p MEDICAL UNIVERSITY OF GRAZ   (Austria)

more..

Author keywords

genetics; humans; leukoencephalopathies; magnetic resonance imaging

Indexed keywords

NUCLEAR RECEPTOR NR4A3;

AFP GENE; ALB GENE; ARTICLE; BRAIN SIZE; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 13; CHROMOSOME 17; FARP1 GENE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GNAI1 GENE; HUMAN; INPP5D GENE; MAJOR CLINICAL STUDY; MRPL18 GENE; NONHUMAN; PRIORITY JOURNAL; RAT; RBM8A GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SIPA1L2 GENE; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; WHITE MATTER; WHITE MATTER HYPERINTENSITY; XPNPEP1 GENE; AGED; ALZHEIMER DISEASE; ANIMAL; BRAIN; CAUSALITY; DEMENTIA; FEMALE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; LEUKOENCEPHALOPATHIES; MALE; PATHOLOGY; PROCEDURES; RISK FACTOR; SPONTANEOUSLY HYPERTENSIVE RAT; TRANSLATIONAL RESEARCH; WISTAR RAT;

AGED; ALZHEIMER DISEASE; ANIMALS; BRAIN; CAUSALITY; DEMENTIA; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LEUKOENCEPHALOPATHIES; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RATS; RATS, INBRED SHR; RATS, WISTAR; RISK FACTORS; TRANSLATIONAL MEDICAL RESEARCH; WHITE MATTER;

EID: 84922224032     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.007649     Document Type: Article

References (43)

1. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666. doi: 10.1136/bmj.c3666.
2. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12:483-497. doi: 10.1016/S1474-4422(13)70060-7.
3. Wardlaw JM, Allerhand M, Doubal FN, Valdes Hernandez M, Morris Z, Gow AJ, et al. Vascular risk factors, large artery atheroma, and brain white matter hyperintensities. Neurology. 2014;82:1331-1338. doi: 10.1212/WNL.0000000000000312.
4. Kochunov P, Glahn D, Winkler A, Duggirala R, Olvera RL, Cole S, et al. Analysis of genetic variability and whole genome linkage of wholebrain, subcortical, and ependymal hyperintense white matter volume. Stroke. 2009;40:3685-3690. doi: 10.1161/STROKEAHA.109.565390.
5. Yamamoto Y, Craggs L, Baumann M, Kalimo H, Kalaria RN. Review: molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathol Appl Neurobiol. 2011;37:94-113. doi: 10.1111/j.1365-2990.2010.01147.x.
6. Jackson CA, Hutchison A, Dennis MS, Wardlaw JM, Lindgren A, Norrving B, et al. Differing risk factor profiles of ischemic stroke subtypes: evidence for a distinct lacunar arteriopathy? Stroke. 2010;41:624-629. doi: 10.1161/STROKEAHA.109.558809.
7. Fornage M, Debette S, Bis JC, Schmidt H, Ikram MA, Dufouil C, et al. Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol. 2011;69:928-939. doi: 10.1002/ana.22403.
8. Verhaaren BF, de Boer R, Vernooij MW, Rivadeneira F, Uitterlinden AG, Hofman A, et al. Replication study of chr17q25 with cerebral white matter lesion volume. Stroke. 2011;42:3297-3299. doi: 10.1161/STROKEAHA.111.623090.
9. Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell JC, Cheng YC, et al; Australian Stroke Genetics Collaborative; Wellcome Trust Case Control Consortium 2 (WTCCC2); International Stroke Genetics Consortium. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol. 2012;11:951-962. doi: 10.1016/S1474-4422(12)70234-X.
10. Adib-Samii P, Rost N, Traylor M, Devan W, Biffi A, Lanfranconi S, et al; Australian Stroke Genetics Collaborative; Wellcome Trust Case-Control Consortium-2 (WTCCC2); METASTROKE; International Stroke Genetics Consortium. 17q25 Locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke status. Stroke. 2013;44:1609-1615. doi: 10.1161/STROKEAHA.113.679936.
11. Bailey EL, McCulloch J, Sudlow C, Wardlaw JM. Potential animal models of lacunar stroke: a systematic review. Stroke. 2009;40:e451-e458. doi: 10.1161/STROKEAHA.108.528430.
12. Bailey EL, Smith C, Sudlow CM, Wardlaw JM. Is the spontaneously hypertensive stroke prone rat a pertinent model of subcortical ischemic stroke? A systematic review. Int J Stroke. 2011;6:434-444. doi: 10.1111/j.1747-4949.2011.00659.x.
13. Bailey EL, Wardlaw JM, Graham D, Dominiczak AF, Sudlow CL, Smith C. Cerebral small vessel endothelial structural changes predate hypertension in stroke-prone spontaneously hypertensive rats: a blinded, controlled immunohistochemical study of 5- to 21-week old rats. Neuropathol Appl Neurobiol. 2011;37:711-726. doi: 10.1111/j.1365-2990.2011.01170.x.
14. Bailey EL, McBride MW, Beattie W, McClure JD, Graham D, Dominiczak AF, et al. Differential gene expression in multiple neurological, inflammatory and connective tissue pathways in a spontaneous model of human small vessel stroke. Neuropathol Appl Neurobiol. 2014;40:855-872. doi: 10.1111/nan.12116.
15. Atanur SS, Diaz AG, Maratou K, Sarkis A, Rotival M, Game L, et al. Genome sequencing reveals loci under artificial selection that underlie disease phenotypes in the laboratory rat. Cell. 2013;154:691-703. doi: 10.1016/j.cell.2013.06.040.
16. Deary IJ, Gow AJ, Taylor MD, Corley J, Brett C, Wilson V, et al. The Lothian Birth Cohort 1936: a study to examine influences on cognitive ageing from age 11 to age 70 and beyond. BMC Geriatr. 2007;7:28. doi: 10.1186/1471-2318-7-28.
17. Wardlaw JM, Bastin ME, Valdés Hernández MC, Maniega SM, Royle NA, Morris Z, et al. Brain aging, cognition in youth and old age and vascular disease in the Lothian Birth Cohort 1936: rationale, design and methodology of the imaging protocol. Int J Stroke. 2011;6:547-559. doi: 10.1111/j.1747-4949.2011.00683.x.
18. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987;149:351-356. doi: 10.2214/ajr.149.2.351.
19. Hernández Mdel C, Ferguson KJ, Chappell FM, Wardlaw JM. New multispectral MRI data fusion technique for white matter lesion segmentation: method and comparison with thresholding in FLAIR images. Eur Radiol. 2010;20:1684-1691. doi: 10.1007/s00330-010-1718-6.
20. Valdés Hernández Mdel C, Morris Z, Dickie DA, Royle NA, Muñoz Maniega S, Aribisala BS, et al. Close correlation between quantitative and qualitative assessments of white matter lesions. Neuroepidemiology. 2013;40:13-22. doi: 10.1159/000341859.
21. Houlihan LM, Davies G, Tenesa A, Harris SE, Luciano M, Gow AJ, et al. Common variants of large effect in F12, KNG1, and HRG are associated with activated partial thromboplastin time. Am J Hum Genet. 2010;86:626-631. doi: 10.1016/j.ajhg.2010.02.016.
22. Wain LV, Verwoert GC, O'Reilly PF, Shi G, Johnson T, Johnson AD, et al; LifeLines Cohort Study; EchoGen consortium; AortaGen Consortium; CHARGE Consortium Heart Failure Working Group; KidneyGen consortium; CKDGen consortium; Cardiogenics consortium; CardioGram. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet. 2011;43:1005-1011. doi: 10.1038/ng.922.
23. Liu JZ, McRae AF, Nyholt DR, Medland SE, Wray NR, Brown KM, et al; AMFS Investigators. A versatile gene-based test for genome-wide association studies. Am J Hum Genet. 2010;87:139-145. doi: 10.1016/j. ajhg.2010.06.009.
24. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575. doi: 10.1086/519795.
25. Hill WD, Davies G, van de Lagemaat LN, Christoforou A, Marioni RE, Fernandes CP, et al. Human cognitive ability is influenced by genetic variation in components of postsynaptic signalling complexes assembled by NMDA receptors and MAGUK proteins. Transl Psychiatry. 2014;4:e341. doi: 10.1038/tp.2013.114.
26. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545-15550. doi: 10.1073/pnas.0506580102.
27. Wang K, Li M, Bucan M. Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet. 2007;81:1278-1283. doi: 10.1086/522374.
28. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol. 2010;34:816-834. doi: 10.1002/gepi.20533.
29. Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998;316:1236-1238. doi: 10.1136/bmj.316.7139.1236.
30. Grupe A, Li Y, Rowland C, Nowotny P, Hinrichs AL, Smemo S, et al. A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. Am J Hum Genet. 2006;78:78-88. doi: 10.1086/498851
31. Stein JL, Hua X, Lee S, Ho AJ, Leow AD, Toga AW, et al; Alzheimer's Disease Neuroimaging Initiative. Voxelwise genome-wide association study (vGWAS). Neuroimage. 2010;53:1160-1174. doi: 10.1016/j. neuroimage.2010.02.032.
32. Cheadle L, Biederer T. The novel synaptogenic protein Farp1 links postsynaptic cytoskeletal dynamics and transsynaptic organization. J Cell Biol. 2012;199:985-1001. doi: 10.1083/jcb.201205041.
33. Ohsakaya S, Fujikawa M, Hisabori T, Yoshida M. Knockdown of DAPIT (diabetes-associated protein in insulin-sensitive tissue) results in loss of ATP synthase in mitochondria. J Biol Chem. 2011;286:20292-20296. doi: 10.1074/jbc.M110.198523.
34. Waldmann TA, McIntire KR. Serum-alpha-fetoprotein levels in patients with ataxia-telangiectasia. Lancet. 1972;2:1112-1115. doi: 10.1016/S0140-6736(72)92717-1.
35. Ciemins JJ, Horowitz AL. Abnormal white matter signal in ataxia telangiectasia. AJNR Am J Neuroradiol. 2000;21:1483-1485.
36. Grinberg LT, Thal DR. Vascular pathology in the aged human brain. Acta Neuropathol. 2010;119:277-290. doi: 10.1007/s00401-010-0652-7.
37. Farrall AJ, Wardlaw JM. Blood-brain barrier: ageing and microvascular disease-systematic review and meta-analysis. Neurobiol Aging. 2009;30:337-352. doi: 10.1016/j.neurobiolaging.2007.07.015.
38. Silver M, Janousova E, Hua X, Thompson PM, Montana G; Alzheimer's Disease Neuroimaging Initiative. Identification of gene pathways implicated in Alzheimer's disease using longitudinal imaging phenotypes with sparse regression. Neuroimage. 2012;63:1681-1694. doi: 10.1016/j. neuroimage.2012.08.002.
39. Wong J. Altered expression of RNA splicing proteins in Alzheimer's disease patients: evidence from two microarray studies. Dement Geriatr Cogn Dis Extra. 2013;3:74-85. doi: 10.1159/000348406.
40. Alachkar A, Jiang D, Harrison M, Zhou Y, Chen G, Mao Y. An EJC factor RBM8a regulates anxiety behaviors. Curr Mol Med. 2013;13: 887-899. doi: 10.2174/15665240113139990019.
41. Herrmann LL, Le Masurier M, Ebmeier KP. White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry. 2008;79:619-624. doi: 10.1136/jnnp.2007.124651.
42. Valdés Hernández Mdel C, Booth T, Murray C, Gow AJ, Penke L, Morris Z, et al. Brain white matter damage in aging and cognitive ability in youth and older age. Neurobiol Aging. 2013;34:2740-2747. doi: 10.1016/j.neurobiolaging.2013.05.032.
43. Fischer MT, Sharma R, Lim JL, Haider L, Frischer JM, Drexhage J, et al. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain. 2012;135(pt 3):886-899. doi: 10.1093/brain/aws012.